Bausch and Lomb Newswire (Page 6)

Comprehensive Real-Time News Feed for Bausch and Lomb. (Page 6)

Results 101 - 120 of 2,125 in Bausch and Lomb

  1. Valeant: Improved offer for Allergan will not be all in cashRead the original story

    May 20, 2014 | Seeking Alpha

    Valeant intends to sweeten its $45.7B cash-and-stock offer based on feedback that the Canadian company hopes to receive during a meeting with stockholders from both companies on May 28. At the meeting, Valeant also plans to respond to Allergan assertions that Valeant's model is not sustainable, that Bausch & Lomb is not growing, that the company ... (more)

    Comment?

  2. Google hopes fashion expertise will give Glass a boost with new hireRead the original story

    May 16, 2014 | Network World

    Google has hired a former Calvin Klein and Gap executive to help make Glass socially acceptable and turn it into a mainstream product.

    Comment?

  3. Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in AdultsRead the original story

    May 15, 2014 | Drugs.com

    May 16, 2014 - Following a May 15, 2014, meeting with the U.S. Food and Drug Administration , Shire plc , the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete ... (more)

    Comment?

  4. Simply Sunglasses Introduces Options in Prada SunglassesRead the original story

    May 17, 2014 | Release News

    The summer months are fast approaching. It will be time to hit up the pool and soak up some sun.

    Comment?

  5. Google Glass Hopes to Gain Cool Factor by Fashion ExecutiveRead the original story

    May 19, 2014 | Tom's Hardware

    Fashion executive Ivy Ross announced on Google+ that starting Monday, May 19, she will be in charge of Google Glass.

    Comment?

  6. Shire to Submit New Drug Application to FDA for Lifitegrast for Dry Eye Disease in AdultsRead the original story

    May 19, 2014 | Pharmaceutical Processing

    Following a May 15, 2014, meeting with the FDA, Shire intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter of 2015.

    Comment?

  7. Shire plans to submit NDA for lifitegrast to FDARead the original story

    May 5, 2014 | Theflyonthewall.com

    Shire to submit NDA for lifitegrast for adult dry eye disease Shire , following its May 15 meeting with the FDA, announced earlier that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as it completes remaining chemistry and manufacturing ... (more)

    Comment?

  8. Google Names New Head of Its Glass BusinessRead the original story w/Photo

    May 16, 2014 | Wall Street Journal

    She also previously had a design stint at Bausch & Lomb, which makes eye-care products.

    Comment?

  9. A good set of binoculars can make or break the huntRead the original story w/Photo

    May 17, 2014 | O-R Online

    Then again, Tom Turkey is still rounding up a harem of beautiful ladies. And in a few weeks, the young groundhogs will be chomping on alfalfa, and landowners will be pulling hay.

    Comment?

  10. Google hires marketing expert for GlassRead the original story w/Photo

    May 17, 2014 | SFGate

    Google has been busy over the past month getting its Glass wearable computer into the hands of more customers, and now the company has appointed a new leader for the team behind the gadget.

    Comment?

  11. Can high fashion save Google Glass's image problem?Read the original story w/Photo

    May 16, 2014 | Christian Science Monitor

    Google Glass, smart glasses under development by Google, are seen in an undated handout picture released February 20, 2013.

    Comment?

  12. Google's New Glass Boss Begins Job By Asking Existential Smartglassy QuestionsRead the original story

    May 16, 2014 | CIO

    Sure, it's notable that Google's new "head of Glass," Ivy Ross, has a deep background in retail product marketing and brand ID.

    Comment?

  13. Google Glass gets new leader as company hires marketing expertRead the original story

    May 16, 2014 | San Jose Mercury News

    Google has been busy over the past month getting its Glass wearable into the hands of more customers, and now the company has also appointed a new leader for the team behind the gadget.

    Comment?

  14. Valeant to consider breakup after mega deals: investorsRead the original story

    May 16, 2014 | Reuters

    Some analysts have said that an acquisition of Allergan would make Valeant so large that it would become difficult to find meaningful takeover targets that would allow Valeant to continue to grow.

    Comment?

  15. Google hires an Art.com executive to lead its Glass divisionRead the original story w/Photo

    May 16, 2014 | Internet Retailer

    Sales and traffic to online retailers by category and merchant type, data on Amazon and other leading e-retailers, comparisons of leading web retailers, site performance data, more.

    Comment?

  16. Google hires fashion veteran Ivy Ross to lead Glass teamRead the original story

    May 16, 2014 | TechSpot

    Google Glass likely has enough capability to become a mainstream success in its current form but the one thing it is lacking is style.

    Comment?

  17. Valeant ready to beef up bid for maker of BotoxRead the original story

    May 13, 2014 | Fortune

    Valeant, which bought eye-care company Bausch & Lomb last year, said it will share more details in a webcast on May 28. Chairman and CEO J. Michael Pearson said the company will outline for shareholders why its offer is better than Allergan's "go it alone" strategy, reported in the Wall Street Journal .

    Comment?

  18. Valeant to Improve its Hostile Takeover Bid for AllerganRead the original story

    May 13, 2014 | Pharmaceutical Processing

    Valeant Pharmaceuticals International says it will improve its bid of almost $47 billion for Botox-maker Allergan after the U.S. company rejected its hostile takeover offer.

    Comment?

  19. Allergan rejects Valeant's $45.7bn bidRead the original story w/Photo

    May 12, 2014 | Iol.co.za

    A vial of of Botox Cosmetic is arranged for a photograph at the office of Manhattan Dermatology in Manhattan Beach, California, U.S., on Tuesday, April 22, 2014.

    Comment?

  20. Allergan formally rejects Valeant's $46 bln bidRead the original story

    May 12, 2014 | MarketWatch

    Allergan Inc. formally rejected a $46 billion unsolicited takeover bid made by Valeant Pharmaceuticals International Inc., saying the proposal substantially undervalues the Botox maker.

    Comment?